Brand Clinical Dossier • France

La Roche-Posay Skincare Audits

French pharmacy thermal spring water formulas engineered for reactive and atopic skin. Explore decoded INCI decks, pregnancy safety verdicts, fungal acne flags, and routine viscosity steps for La Roche-Posay's top products.

Catalogued Formulations (6)

Independent Pharmacological Audits
moisturizerStep 6 • BOTH

Cicaplast Baume B5+ Ultra-Repairing Balm

Multi-purpose recovery balm formulated with 5% panthenol and madecassoside that accelerates epidermal re-epithelialization in irritated, sensitized skin.

Panthenol 5%MadecassosideTribioma Prebiotic ComplexShea Butter
View INCI Audit & Conflicts→
treatmentStep 4 • BOTH

Effaclar Duo+ Acne Treatment

Dual-action blemish spot and global face treatment that targets active acne lesions while reducing red and brown post-inflammatory hyperpigmentation.

NiacinamideSalicylic AcidLHA (Lipohydroxy Acid)Zinc PCA
View INCI Audit & Conflicts→
sunscreenStep 7 • AM

Anthelios UVMune 400 Invisible Fluid SPF 50+

Groundbreaking photoprotective fluid filtering ultra-long UVA rays (380–400nm) using patented Mexoryl 400 technology.

Mexoryl 400 (Ultra-Long UVA)Netlock TechnologyTocopherol
View INCI Audit & Conflicts→
sunscreenStep 7 • AM

Anthelios UVMune 400 Invisible Fluid SPF50+

Benchmark European daily sunscreen powered by Mexoryl 400, offering unprecedented protection against ultra-long UVA rays (380–400nm) that cause deep cellular photo-aging.

Mexoryl 400 (Long-UVA Filter)Netlock Micro-Crystal MatrixTocopherol
View INCI Audit & Conflicts→
sunscreenStep 1 • AM

Anthelios UVMune 400 Invisible Fluid SPF 50+

Pioneering European sunscreen featuring Mexoryl 400 (Methoxypropylamino Cyclohexenylidene Ethoxyethylcyanoacetate), the first UV filter capable of absorbing ultra-long UVA rays between 380nm and 400nm — the primary wavelengths driving deep dermal solar elastosis and persistent melasma.

ceramides
View INCI Audit & Conflicts→
treatmentStep 4 • AM

Effaclar Duo+ M Anti-Blemish Treatment

Multi-targeted acne and post-inflammatory erythema treatment combining Niacinamide, Lipohydroxy Acid (Capryloyl Salicylic Acid), Salicylic Acid, Zinc PCA, and patented Phylobioma postbiotic extract targeting Cutibacterium acnes phylotype IA1.

niacinamidesalicylic-acid
View INCI Audit & Conflicts→